Acadia Healthcare Company Inc vs Charles River Laboratories Intl. Inc — how do they compare? Acadia Healthcare Company Inc trades at $31.35 (market cap $2.90B), while Charles River Laboratories Intl. Inc trades at $282.01 (market cap $13.46B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 4.6× Acadia Healthcare Company Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Acadia Healthcare Company Inc nearer its low. Which is the better fit depends on your goals.
| ACHC | CRL | |
|---|---|---|
Market Cap | $2.90B | $13.46B |
Sector | Health | Health |
52-Week High | $35.61 | $282.00 |
52-Week Low | $11.68 | $145.57 |
Enterprise Value | $5.29B | $16.30B |
Trailing returns across standard periods
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →